Lessons from the pandemic messaging mess
New approaches are emerging, though some experts worry they’re uncommon and not always taken seriously in larger pandemic preparedness discussions.
Stay updated with breaking news from Ruth Reader. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New approaches are emerging, though some experts worry they’re uncommon and not always taken seriously in larger pandemic preparedness discussions.
Eli Lilly and Co. disclosed late Thursday that the FDA rejected its application for accelerated approval of its Alzheimer’s disease drug candidate.
CMS Administrator Chiquita Brooks-LaSure announced that the first 10 Medicare Part D drugs selected for price negotiations will be made public by Sept. 1.
A working group formed by the Center for Strategic and International Studies, a nonprofit research policy center, released a report Thursday that examines what it calls the CDC’s “moment of peril.”
The Centers for Disease Control and Prevention now reports that the Omicron variant XBB.1.5 is now the dominant SARS-CoV-2 strain in the nation.